In the present study, it was hypothesized that M2-like macrophages-derived CCL17 could facilitate ESCC malignant progression through activating CCR4 signaling to mediate ERK/PD‐L1 pathway. Here, CCL17 is linked to esophageal squamous cell carcinoma.